Electroceuticals: Reinventing Chronic Disease Care Without Drugs

In this episode of Frost & Sullivan’s Growth Podcast, we explore how electroceuticals are transforming chronic disease management—from pain to neurodegeneration. With wearable formats, AI-driven personalization, and hybrid therapy models, this market is scaling fast and redefining long-term care. 🎯 Key takeaways include: • How electroceuticals offer scalable, non-invasive alternatives to chronic drug use • Role of AI in driving real-time therapy optimization and patient-specific outcomes • Top innovators including Boston Scientific, Sinaptica, and Nalu Medical • Why multimodal systems are the next leap in non-pharmacological care • Business and investment opportunities shaping the bioelectronic medicine frontier This episode is essential for leaders across medtech, digital therapeutics, and chronic care innovation. frost.com | hello@frost.com